1-11 of 11
Hannah M. Linden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?

Hannah M. Linden, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2015–2016.
https://doi.org/10.1158/1078-0432.CCR-23-0393
Published: 01 June 2023
View article titled, Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?
Open the PDF for Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments? in another window
Journal Articles

FDG PET and FES PET Predict PFS on Endocrine Therapy—Response

Brenda F. Kurland, Lanell M. Peterson, Hannah M. Linden, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (1): 249–250.
https://doi.org/10.1158/1078-0432.CCR-17-2980
Published: 02 January 2018
View article titled, FDG PET and FES PET Predict PFS on Endocrine Therapy—Response
Open the PDF for FDG PET and FES PET Predict PFS on Endocrine Therapy—Response in another window
Journal Articles

FDG PET and FES PET Predict PFS on Endocrine Therapy—Response

Brenda F. Kurland, Hannah M. Linden, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (13): 3475.
https://doi.org/10.1158/1078-0432.CCR-17-0479
Published: 02 July 2017
View article titled, FDG PET and FES PET Predict PFS on Endocrine Therapy—Response
Open the PDF for FDG PET and FES PET Predict PFS on Endocrine Therapy—Response in another window
Journal Articles

Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer

Brenda F. Kurland, Lanell M. Peterson, Jean H. Lee, Erin K. Schubert, Erin R. Currin, Jeanne M. Link, Kenneth A. Krohn, David A. Mankoff, Hannah M. Linden
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 407–415.
https://doi.org/10.1158/1078-0432.CCR-16-0362
Published: 15 January 2017
View article titled, Estrogen Receptor Binding (<sup>18</sup>F-FES PET) and Glycolytic Activity (<sup>18</sup>F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER<sup>+</sup> Breast Cancer
Open the PDF for Estrogen Receptor Binding (<sup>18</sup>F-FES PET) and Glycolytic Activity (<sup>18</sup>F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER<sup>+</sup> Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

Eve T. Rodler, Brenda F. Kurland, Melissa Griffin, Julie R. Gralow, Peggy Porter, Rosa F. Yeh, Vijayakrishna K. Gadi, Jamie Guenthoer, Jan H. Beumer, Larissa Korde, Sandra Strychor, Brian F. Kiesel, Hannah M. Linden, John A. Thompson, Elizabeth Swisher, Xiaoyu Chai, Stacie Shepherd, Vincent Giranda, Jennifer M. Specht
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (12): 2855–2864.
https://doi.org/10.1158/1078-0432.CCR-15-2137
Published: 14 June 2016
View article titled, Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <em>BRCA</em> Mutation–Associated Breast Cancer
Open the PDF for Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <em>BRCA</em> Mutation–Associated Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Quantitative Imaging in Cancer Clinical Trials

Thomas E. Yankeelov, David A. Mankoff, Lawrence H. Schwartz, Frank S. Lieberman, John M. Buatti, James M. Mountz, Bradley J. Erickson, Fiona M.M. Fennessy, Wei Huang, Jayashree Kalpathy-Cramer, Richard L. Wahl, Hannah M. Linden, Paul E. Kinahan, Binsheng Zhao, Nola M. Hylton, Robert J. Gillies, Laurence Clarke, Robert Nordstrom, Daniel L. Rubin
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 284–290.
https://doi.org/10.1158/1078-0432.CCR-14-3336
Published: 14 January 2016
View article titled, Quantitative Imaging in Cancer Clinical Trials
Open the PDF for Quantitative Imaging in Cancer Clinical Trials in another window
Journal Articles

Molecular Imaging to Guide Targeted Therapy

David A. Mankoff, Hannah M. Linden, Jeanne M. Link, William E. Barlow, Kenneth A. Krohn
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): PL-31.
Published: 15 August 2014
View article titled, Molecular Imaging to Guide Targeted Therapy
Journal Articles

Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer

Hannah M. Linden, Brenda F. Kurland, Lanell M. Peterson, Erin K. Schubert, Julie R. Gralow, Jennifer M. Specht, Georgiana K. Ellis, Thomas J. Lawton, Robert B. Livingston, Philip H. Petra, Jeanne M. Link, Kenneth A. Krohn, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4799–4805.
https://doi.org/10.1158/1078-0432.CCR-10-3321
Published: 17 July 2011
View article titled, Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
Open the PDF for Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake

Lisa K. Dunnwald, Robert K. Doot, Jennifer M. Specht, Julie R. Gralow, Georgiana K. Ellis, Robert B. Livingston, Hannah M. Linden, Vijayakrishna K. Gadi, Brenda F. Kurland, Erin K. Schubert, Mark Muzi, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2400–2409.
https://doi.org/10.1158/1078-0432.CCR-10-2649
Published: 14 April 2011
View article titled, PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake
Open the PDF for PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake in another window
Journal Articles

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer

Jennifer M. Specht, Brenda F. Kurland, Susan K. Montgomery, Lisa K. Dunnwald, Robert K. Doot, Julie R. Gralow, Georgina K. Ellis, Hannah M. Linden, Robert B. Livingston, Kimberly H. Allison, Erin K. Schubert, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2803–2810.
https://doi.org/10.1158/1078-0432.CCR-10-0026
Published: 13 May 2010
View article titled, Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer
Open the PDF for Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer in another window
Journal Articles

Monitoring Targeted Therapy: Is Fluorodeoxylucose Uptake a Marker of Early Response?

Hannah M. Linden, Kenneth A. Krohn, Robert B. Livingston, David A. Mankoff
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5608–5610.
https://doi.org/10.1158/1078-0432.CCR-06-1152
Published: 04 October 2006
View article titled, Monitoring Targeted Therapy: Is Fluorodeoxylucose Uptake a Marker of Early Response?
Open the PDF for Monitoring Targeted Therapy: Is Fluorodeoxylucose Uptake a Marker of Early Response? in another window